Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

DaVita logoDaVita DVA

DaVita reported consolidated revenues of $3.187 billion, operating income of $506 million and diluted earnings per share of $2.50 (adjusted diluted earnings per share of $2.59) for the quarter ended June 30, 2024.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. DaVita reported consolidated revenues of $3.187 billion, operating income of $506 million and diluted earnings per share of $2.50 (adjusted diluted earnings per share of $2.59) for the quarter ended June 30, 2024.

  2. The company said operating cash flow was $799 million and free cash flow was $654 million for Q2 2024. It said operating cash flow was $450 million and free cash flow was $260 million in the year-earlier period.

  3. The company said it repurchased 2.7 million shares for $376 million in Q2 2024, at an average price paid of $140.14 per share. It also said it extended the maturity date for a portion of Term Loan B-1 (aggregate principal amount of $1,640 million) in May 2024.

  4. The company said it no longer excludes center closure costs from its 2024 outlook after an SEC Staff comment letter. As a result, it said the current outlook no longer excludes approximately $60 million in center closure costs. The current 2024 free cash flow outlook is $950 million to $1,200 million.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

DaVita QQ2 2024 revenue, operating income and diluted EPS

DaVita reported consolidated revenues of $3.187 billion, operating income of $506 million and diluted earnings per share of $2.50 (adjusted diluted earnings per share of $2.59) for the quarter ended June 30, 2024.

Source · Based on the filing body and exhibits

Q2 2024 operating and free cash flow

The company said operating cash flow was $799 million and free cash flow was $654 million for Q2 2024. It said operating cash flow was $450 million and free cash flow was $260 million in the year-earlier period.

Source · Based on the filing body and exhibits

Share repurchases and Term Loan B-1 maturity extension

The company said it repurchased 2.7 million shares for $376 million in Q2 2024, at an average price paid of $140.14 per share. It also said it extended the maturity date for a portion of Term Loan B-1 (aggregate principal amount of $1,640 million) in May 2024.

Source · Based on the filing body and exhibits

2024 full-year outlook and center closure cost presentation change

The company said it no longer excludes center closure costs from its 2024 outlook after an SEC Staff comment letter. As a result, it said the current outlook no longer excludes approximately $60 million in center closure costs. The current 2024 free cash flow outlook is $950 million to $1,200 million.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.